Correlation Between Aclaris Therapeutics and Fonar
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Fonar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Fonar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Fonar, you can compare the effects of market volatilities on Aclaris Therapeutics and Fonar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Fonar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Fonar.
Diversification Opportunities for Aclaris Therapeutics and Fonar
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aclaris and Fonar is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Fonar in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fonar and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Fonar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fonar has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Fonar go up and down completely randomly.
Pair Corralation between Aclaris Therapeutics and Fonar
Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 3.25 times more return on investment than Fonar. However, Aclaris Therapeutics is 3.25 times more volatile than Fonar. It trades about 0.02 of its potential returns per unit of risk. Fonar is currently generating about 0.0 per unit of risk. If you would invest 1,518 in Aclaris Therapeutics on August 28, 2024 and sell it today you would lose (1,119) from holding Aclaris Therapeutics or give up 73.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aclaris Therapeutics vs. Fonar
Performance |
| Timeline |
| Aclaris Therapeutics |
| Fonar |
Aclaris Therapeutics and Fonar Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aclaris Therapeutics and Fonar
The main advantage of trading using opposite Aclaris Therapeutics and Fonar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Fonar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fonar will offset losses from the drop in Fonar's long position.| Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
| Fonar vs. Burning Rock Biotech | Fonar vs. Sera Prognostics | Fonar vs. Exagen Inc | Fonar vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |